Animal Health Market Research Reports

Animal Health Market Overview

The global animal health market is projected to reach USD 66.86 billion in 2025 and expand significantly to USD 156.43 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.21%. This rapid growth is driven by rising demand for protein-rich diets, growing awareness of pet health and wellness, increasing incidences of zoonotic and livestock diseases, and advances in veterinary diagnostics, therapeutics, and digital monitoring technologies. The livestock segment remains the dominant force in the animal health market. As the global population increases, particularly in Asia and Africa, demand for meat, dairy, and poultry products continues to rise. To meet this demand sustainably, livestock producers are investing heavily in preventive healthcare, including vaccines, parasiticides, and productivity-enhancing nutritional supplements. Countries such as India, China, Brazil, and the U.S. are witnessing heightened focus on improving livestock productivity through enhanced veterinary care, especially for cattle, pigs, and poultry.

Pet health is another fast-growing segment, fueled by increasing pet ownership, especially in urban areas across North America, Europe, and Asia-Pacific. The shift from pet ownership to “pet parenting” has led to greater spending on preventive and therapeutic veterinary services. Between 2024 and 2025, the companion animal segment is expected to grow steadily, with high demand for flea and tick treatments, specialized medications for chronic diseases (such as arthritis and diabetes), and innovations in pet diagnostics, including wearable health trackers and point-of-care devices. Technological innovation is playing a transformative role in the animal health market. Advanced diagnostic tools, real-time herd management software, artificial intelligence (AI)-powered disease detection, and telemedicine for pets are revolutionizing veterinary practices. The use of genomics and biotechnology in vaccine development and breeding programs is also expanding, offering solutions tailored to specific regional disease patterns and animal genetics.

North America is set to maintain its leadership in the animal health market in 2025, driven by a highly structured veterinary infrastructure, robust pet care expenditure, and strong demand for premium animal health products. The United States in particular is a major market for companion animal pharmaceuticals and veterinary services, with rising adoption of health insurance for pets further driving sector growth. Asia-Pacific is expected to be the fastest-growing region through 2030, supported by increasing livestock production, government initiatives to control animal-borne diseases, and growing consumer willingness to invest in both farm and companion animal health. China and India are key contributors, accounting for a significant share of livestock and a rapidly expanding urban middle class that is boosting demand for pet care services. Europe follows closely with a strong veterinary pharmaceutical industry and a growing trend toward sustainable livestock farming. The region's stringent animal welfare and antimicrobial usage regulations are prompting innovations in vaccine development, probiotics, and non-antibiotic treatment alternatives.

Top Countries Contributing Animal Health Market

United States (2025 Market Size: USD 28.4 billion)

According to Cognitive Market Research, the United States is expected to lead the global animal health market in 2025, with a projected market size of USD 28.4 billion. The U.S. is home to a large and growing pet population, alongside a well-established livestock sector, both of which contribute significantly to market demand. The growing trend of pet ownership and the increased focus on livestock disease management are key drivers of the market's expansion. The country's high demand for veterinary services, pharmaceuticals, and preventive care products is expected to remain robust. Additionally, the presence of major global players like Zoetis and Merck Animal Health further strengthens the U.S.'s dominance in the market. Government initiatives promoting animal welfare and food safety are also boosting demand for advanced diagnostic tools and vaccines. The U.S. market is poised to maintain strong growth due to continuous advancements in animal health technologies and healthcare trends.

China (2025 Market Size: USD 13.2 billion)

China is projected to hold the second-largest share of the global animal health market in 2025, with an estimated market size of USD 13.2 billion. The growing demand for animal products, coupled with increased awareness of animal health, has driven significant investments in veterinary care and animal pharmaceuticals. China's expansive agricultural industry, which includes a large population of livestock, particularly pigs, has seen a surge in demand for vaccines and antibiotics to manage diseases like African Swine Fever (ASF). Additionally, the rise in pet ownership in urban areas has contributed to increased demand for pet healthcare products. Government regulations and initiatives focused on improving livestock health and animal welfare have further stimulated market growth. The presence of local and international veterinary companies in China also ensures competitive market dynamics, positioning it as a major player in the global animal health market.

Brazil (2025 Market Size: USD 6.4 billion)

Brazil is anticipated to rank third in the global animal health market in 2025, with a projected market size of USD 6.4 billion. As a major exporter of beef, poultry, and other animal products, Brazil's livestock industry plays a critical role in global trade, driving demand for veterinary pharmaceuticals and vaccines. The country's vast agricultural sector, particularly its cattle ranching industry, is increasingly focused on improving animal health to prevent disease outbreaks that could affect productivity and exports. Brazil's growing pet population also contributes to the demand for animal health products, as more pet owners seek preventive care and treatment options. Additionally, the country's focus on sustainability and animal welfare has led to the adoption of modern practices in animal health management. As Brazil continues to strengthen its agricultural industry, the market for veterinary services and animal health products is expected to expand significantly.

Germany (2025 Market Size: USD 5.6 billion)

Germany is projected to secure the fourth position in the global animal health market by 2025, with an estimated market size of USD 5.6 billion. The country's strong agricultural sector, particularly its livestock farming and poultry industries, creates a steady demand for veterinary drugs and disease prevention solutions. Germany also has a robust pet care market, with an increasing number of pet owners seeking high-quality products and services. The German government’s stringent regulations on animal health and food safety have led to increased investments in diagnostic tools and vaccines. The country is home to several prominent animal health companies, such as Boehringer Ingelheim Animal Health, which focus on developing innovative solutions for both farm animals and companion animals. Germany’s commitment to sustainable agriculture and animal welfare further drives the market, as industry stakeholders strive to meet the growing demands of animal health and safety.

United Kingdom (2025 Market Size: USD 4.5 billion)

The United Kingdom is expected to be the fifth-largest contributor to the global animal health market in 2025, with a projected market size of USD 4.5 billion. The UK’s well-established agricultural sector, which includes beef, poultry, and dairy farming, is a key driver of demand for veterinary pharmaceuticals and vaccines. The country has also seen a rise in pet ownership, leading to increased demand for companion animal products such as preventive medicines, flea treatments, and dietary supplements. Government regulations ensuring high standards for animal welfare and food safety are further propelling the need for advanced veterinary care and diagnostic solutions. In addition, the UK’s strong research and development capabilities in veterinary sciences have contributed to innovations in disease prevention and treatment. As the market continues to expand, the UK remains a major player in driving the growth of the global animal health industry.

France (2025 Market Size: USD 3.8 billion)

As per Cognitive Market Research, France is projected to hold the sixth position in the global animal health market in 2025, with an estimated market size of USD 3.8 billion. The French animal health market is driven by the country’s prominent agricultural sector, which includes beef, dairy, and poultry production. The need for effective veterinary care, particularly in preventing infectious diseases and ensuring livestock productivity, has spurred demand for vaccines, antibiotics, and diagnostic solutions. France also has a strong market for pet health products, reflecting the growing trend of pet ownership. The government’s focus on improving animal welfare standards and food safety regulations further boosts the market’s growth. Additionally, France is home to several leading animal health companies, which invest heavily in research and development to address emerging challenges in animal health. The combination of agricultural demand and pet healthcare trends positions France as a key contributor to the global market.

India (2025 Market Size: USD 3.1 billion)

India is expected to secure the seventh position in the global animal health market by 2025, with a projected market size of USD 3.1 billion. The country’s large agricultural industry, including its vast cattle and poultry populations, drives the demand for veterinary pharmaceuticals, particularly antibiotics and vaccines. As India’s livestock sector continues to expand, the need for disease management and prevention grows, creating significant opportunities for animal health companies. Additionally, the rise in urban pet ownership in India is contributing to increased demand for pet healthcare products, such as vaccines, grooming products, and nutritional supplements. Government initiatives focused on improving livestock health and promoting animal welfare are also playing a pivotal role in market expansion. With a large and growing population of both farm and companion animals, India represents a rapidly developing market for veterinary products and services, positioning it as an emerging leader in the animal health sector.

Mexico (2025 Market Size: USD 2.5 billion)

Mexico is anticipated to hold the eighth position in the global animal health market by 2025, with a projected market size of USD 2.5 billion. The country’s growing agricultural industry, including its significant beef and poultry production, is a key driver of the market. Mexico's livestock industry relies heavily on veterinary care to manage diseases and improve productivity, leading to an increased demand for vaccines, antibiotics, and diagnostic tools. Additionally, the rise in pet ownership in urban areas has contributed to the growth of the pet care market, with pet owners seeking high-quality products to ensure their animals’ health. Government initiatives aimed at improving livestock health, along with stricter regulations on food safety and animal welfare, are also supporting market growth. As Mexico continues to strengthen its agricultural and pet care sectors, it is expected to experience steady growth in the animal health market.

Japan (2025 Market Size: USD 2.2 billion)

Japan is projected to be the ninth-largest contributor to the global animal health market in 2025, with a market size of USD 2.2 billion. The country’s pet care market is one of the largest in Asia, with a high demand for veterinary services and products, including vaccines, flea treatments, and dietary supplements. Additionally, Japan’s agricultural industry, including dairy and poultry production, is increasing its focus on disease prevention and livestock health. This demand is fueling the market for veterinary drugs and diagnostic solutions. The Japanese government’s stringent regulations on animal welfare and food safety also support the growth of the animal health market, encouraging the adoption of advanced technologies. Japan’s emphasis on high-quality veterinary care, combined with its aging population of pets and livestock, ensures sustained demand for animal health products and services in the coming years.

Australia (2025 Market Size: USD 2.1 billion)

Australia is expected to rank tenth in the global animal health market by 2025, with a projected market size of USD 2.1 billion. The country’s strong agricultural industry, particularly in livestock and poultry production, drives the demand for veterinary products such as vaccines and antibiotics. Australia also has a growing pet care market, with an increasing number of pet owners seeking products for preventive care and treatment. The Australian government’s focus on improving animal health standards and ensuring food safety has led to an increase in demand for diagnostic tools and veterinary care. Additionally, Australia’s commitment to sustainability and animal welfare has encouraged the adoption of eco-friendly veterinary solutions. With a strong focus on both livestock health and pet care, Australia is expected to remain a significant player in the global animal health market.

PESTEL Analysis of Animal Health Market

Political

The animal health market is significantly influenced by political frameworks, including government policies on veterinary care, livestock management, public health coordination, and food safety regulations. Political will to strengthen disease surveillance, support animal vaccination programs, and bolster veterinary infrastructure determines the market’s expansion particularly in emerging economies. Governments often subsidize animal healthcare to maintain national food security and rural livelihoods, especially for livestock such as cattle, poultry, and swine. International trade agreements related to meat, dairy, and animal products also impact animal health compliance, with importing nations demanding strict adherence to health certifications and traceability protocols. The role of political institutions such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) is pivotal in setting cross-border animal disease control strategies. Furthermore, political action around One Health initiatives which link human, animal, and environmental health has intensified post-COVID-19, creating funding and policy opportunities for integrated animal health solutions. However, inconsistent veterinary policies, lack of enforcement, or political instability can hinder market growth and raise the risk of zoonotic disease outbreaks.

Economic

Economic factors play a central role in shaping the animal health market, particularly through livestock ownership patterns, consumer spending on pets, agricultural productivity, and global meat demand. In developing countries, animal health investments are closely linked to the economic viability of small-scale farmers and food producers, who rely heavily on livestock for income, transportation, and food. As GDP per capita increases, there’s also a notable rise in companion animal ownership, leading to a surge in demand for pet diagnostics, preventive care, and specialty veterinary services. The growth of meat and dairy exports supports veterinary pharmaceutical markets, particularly in countries like the U.S., Brazil, China, and India. However, fluctuations in feed prices, animal product demand, and farmer income can limit spending on animal health. Moreover, the rising cost of veterinary R&D and clinical trials affects drug pricing and market entry for new treatments. Economic disruptions such as inflation, trade restrictions, and pandemics also influence consumption patterns and health investment decisions. Overall, the market benefits from increased consumer willingness to invest in animal wellbeing, but remains vulnerable to economic downturns and agricultural volatility.

Social

Social factors driving the animal health market include growing pet humanization, changing dietary preferences, public health awareness, and attitudes toward animal welfare. In urban areas, companion animals are increasingly considered family members, leading to rising demand for vaccinations, grooming, behavioral therapy, and advanced veterinary procedures such as surgeries and diagnostics. This shift is especially pronounced in North America, Western Europe, and parts of Asia-Pacific. Simultaneously, there is a growing public concern about zoonotic diseases such as avian influenza, rabies, and brucellosis which has raised awareness about animal disease prevention and encouraged investment in early detection and reporting mechanisms. Consumer preference for ethically sourced and antibiotic-free animal products is also influencing farm-level practices and driving demand for vaccines and biosecurity solutions. In livestock-dominant societies, traditional practices and cultural norms often determine the extent of veterinary service adoption. In both pet and production sectors, rising expectations for animal rights and welfare standards are shaping public policy and driving demand for humane treatment, traceability, and transparent veterinary care systems. Education campaigns and social behavior play a pivotal role in improving compliance with animal health protocols.

Technological

The animal health market is undergoing a technological transformation, driven by advancements in biotechnology, diagnostics, digital health platforms, and vaccine delivery systems. Breakthroughs in genomics and molecular biology have paved the way for next-generation vaccines, monoclonal antibodies, and precision medicine for both companion and farm animals. Rapid diagnostic kits, biosensors, and lab-on-a-chip devices are improving disease detection at the point of care, especially in remote or underserved regions. Mobile apps and telemedicine platforms are helping veterinarians remotely monitor animal conditions, especially in pet care and rural livestock management. Wearable health trackers and RFID-enabled collars are providing real-time insights into pet activity, location, and wellness. In livestock management, automated feeding systems, drones for herd monitoring, and predictive analytics are enabling data-driven decision-making. The use of AI in clinical trials and digital platforms for veterinary practice management is also accelerating the commercialization of new products and services. Importantly, technological innovation is central to reducing antibiotic use and promoting preventive care through improved biosecurity and vaccination programs. The convergence of digital, biological, and agricultural technologies is rapidly redefining the contours of the animal health landscape.

Environmental

Environmental conditions have a direct and multifaceted impact on the animal health market. Climate change, deforestation, and habitat loss are increasing the incidence and geographic spread of animal diseases both zoonotic and vector-borne. Higher temperatures and shifting weather patterns are influencing parasite life cycles, migration routes, and disease outbreaks, which in turn raise the need for region-specific surveillance, veterinary intervention, and early warning systems. Livestock emissions and intensive farming are drawing criticism for their environmental footprint, pushing the industry toward sustainable practices such as rotational grazing, organic feed, and eco-friendly waste management systems. Regulatory pressure to reduce antibiotic residues in water and soil is promoting alternative health solutions such as probiotics, vaccines, and phytogenic feed additives. The growth of aquaculture, often affected by water pollution and algae blooms, is also contributing to the need for more resilient animal health practices in fish farming. Furthermore, public concerns over biodiversity and the encroachment of animal agriculture into natural ecosystems are influencing animal welfare standards and biosecurity protocols. In essence, environmental stewardship is becoming an integral part of long-term animal health strategies.

Legal

The legal environment for the animal health market is defined by stringent regulatory frameworks, veterinary drug approvals, intellectual property rights, and international health compliance standards. Veterinary pharmaceuticals and biologics are regulated by authorities such as the U.S. FDA Center for Veterinary Medicine, the European Medicines Agency (EMA), and national veterinary councils. The legal process for product registration, labeling, residue limits, and post-market surveillance can be lengthy and expensive, often deterring smaller firms or startups. Import-export regulations for live animals, meat, and animal products require compliance with health certificates, quarantine laws, and WTO-sanctioned sanitary and phytosanitary (SPS) measures. Intellectual property protections for veterinary drugs, diagnostics, and vaccine technologies are critical for innovation but can create market exclusivity concerns. Legal liabilities related to vaccine failures, antibiotic resistance, or side effects in animals are rising, especially in markets with increasing pet insurance coverage. Furthermore, laws on antimicrobial resistance (AMR), animal testing alternatives, animal cruelty, and clinical transparency are evolving rapidly, compelling companies to rethink product design, trial practices, and marketing strategies. Navigating the regulatory maze is a core competency for long-term success in this highly scrutinized market.

Key Players of the Animal Health Market

Zoetis Inc.

Zoetis is a global leader in the animal health market, known for its extensive portfolio of vaccines, diagnostics, and pharmaceutical products. The company serves both the livestock and companion animal segments, focusing on advancing the health and well-being of animals through innovative solutions. In 2024, Zoetis continued to expand its portfolio with the introduction of new biologics and medications designed to address common animal health issues, such as infectious diseases and parasitic infestations. Zoetis has also been at the forefront of advancing precision medicine and digital health tools, which help optimize animal health management practices. As consumer demand for high-quality meat and dairy products increases globally, Zoetis’ comprehensive product offerings, backed by robust research and development, ensure its prominent position in the growing animal health market.

Boehringer Ingelheim

Boehringer Ingelheim is a global leader in the animal health sector, known for its wide range of vaccines, medicines, and health products for both farm and pet animals. The company has a strong presence in the livestock segment, where it focuses on improving animal productivity and disease prevention, particularly in cattle, poultry, and swine. In 2024, Boehringer Ingelheim introduced several new vaccines and treatments designed to combat infectious diseases, which are critical to ensuring the safety of food supplies. The company is also a key player in the pet healthcare market, offering advanced treatments for chronic conditions such as arthritis and allergies. Boehringer Ingelheim’s commitment to sustainability and its increasing focus on digital health solutions are driving its continued growth in the animal health industry, ensuring it remains at the forefront of the sector.

Elanco Animal Health

Elanco Animal Health, a leading animal health company, focuses on providing a broad range of treatments and preventative solutions for both companion and livestock animals. The company’s products include antibiotics, vaccines, and parasiticides, all aimed at improving the health and well-being of animals worldwide. In 2024, Elanco strengthened its presence in the pet care market, introducing innovative products to address the growing concerns related to pet obesity, skin conditions, and allergies. The company’s strategic acquisitions and investments in R&D have enabled it to expand its product offerings and enhance its competitive position in the animal health market. Elanco’s commitment to providing sustainable solutions for the agriculture sector, as well as its focus on global animal health initiatives, ensures its continued growth as a major player in this rapidly expanding market.

Merck Animal Health

Merck Animal Health, a division of Merck & Co., is a prominent player in the global animal health market, offering vaccines, biologics, and pharmaceuticals for livestock and companion animals. The company is focused on improving animal welfare, food safety, and productivity. In 2024, Merck introduced new livestock vaccines designed to prevent diseases that threaten the productivity of poultry, swine, and cattle farms. Merck is also active in the development of novel antimicrobial treatments to combat the growing issue of antibiotic resistance in veterinary medicine. The company’s advanced digital technologies, including predictive analytics and data-driven health management tools, are further enhancing its value proposition in the market. With an increasing emphasis on animal welfare and food security, Merck continues to play a key role in advancing the health of animals worldwide.

Vetoquinol

Vetoquinol is an innovative player in the global animal health industry, offering a wide range of pharmaceuticals, vaccines, and diagnostic solutions for both companion and farm animals. The company has a strong focus on veterinary treatments for small animals such as dogs and cats, as well as for livestock species like cattle and poultry. In 2024, Vetoquinol launched several new solutions aimed at improving pet care, including treatments for joint health, dermatological conditions, and parasitic infestations. Vetoquinol is also actively expanding its presence in emerging markets, where demand for high-quality animal healthcare products is increasing. As the market for animal health products continues to grow, Vetoquinol’s focus on high-quality, affordable, and sustainable veterinary solutions ensures its continued growth in the industry.

Cargill Animal Nutrition

Cargill Animal Nutrition, a subsidiary of Cargill, provides essential nutrition and health solutions for livestock, poultry, and aquaculture industries. The company’s offerings include animal feed, health supplements, and probiotics, all aimed at improving the overall health and productivity of animals. Cargill is focused on improving the sustainability of the global food supply chain by ensuring that animals receive optimal nutrition that supports both their health and the quality of the products they provide. In 2024, Cargill expanded its product portfolio with the introduction of new feed additives designed to enhance animal performance and gut health. The company is also focused on reducing the environmental impact of animal farming through innovations in feed formulation and management practices. Cargill’s ongoing investment in research and development positions it as a key player in the growing animal health market.

Bayer Animal Health

Bayer Animal Health, a division of Bayer AG, is a major player in the global animal health market, providing innovative health solutions for both companion and livestock animals. The company offers a wide range of vaccines, parasiticides, and antibiotics that help prevent and treat common diseases in animals. In 2024, Bayer continued to expand its offerings with the introduction of new treatments for parasitic infections and vaccines for emerging diseases. Bayer is also involved in several initiatives aimed at improving the overall sustainability of the animal farming industry, including the development of solutions that help reduce the environmental impact of animal agriculture. As the demand for high-quality animal health products continues to grow, Bayer’s strong portfolio and commitment to sustainability will ensure its continued success in the market.

IDEXX Laboratories

IDEXX Laboratories is a global leader in veterinary diagnostics, offering a wide range of diagnostic tests and solutions for companion animals, livestock, and poultry. The company provides veterinarians with advanced tools for disease detection, health monitoring, and overall animal wellness. In 2024, IDEXX launched several new diagnostic platforms designed to improve the speed and accuracy of disease testing, helping veterinarians provide better care to their patients. IDEXX’s focus on innovation in the field of veterinary diagnostics, coupled with its global reach, ensures its leadership in the growing animal health market. The increasing adoption of its solutions by veterinary clinics and animal hospitals worldwide underscores IDEXX's growing influence in the animal healthcare industry.

Impact of Trump Tariff on Animal Health Market

The Trump administration’s imposition of tariffs on Chinese goods had a significant and multifaceted impact on the animal health market in the United States. This market, which encompasses pharmaceuticals, vaccines, feed additives, diagnostic tools, and medical equipment used in the care and treatment of livestock and companion animals, is deeply reliant on global supply chains—many of which involve raw materials, active pharmaceutical ingredients (APIs), and finished products imported from China. With the implementation of tariffs ranging from 10% to 25% on a wide array of goods, including veterinary medicines and related components, the cost structure across the animal health value chain was disrupted. Companies that sourced essential ingredients or finished products from Chinese manufacturers faced higher import costs, which in many cases were passed along the chain to veterinary service providers, livestock producers, and eventually to end consumers.

This increase in costs affected both the livestock and companion animal segments. In the livestock sector, where margins are already thin and producers operate under tight cost controls, higher prices for animal health products such as antibiotics, vaccines, and nutritional supplements led to increased operational expenditures. For small- to mid-sized farms, which lack the scale to absorb such cost hikes, profitability was adversely affected. In the companion animal segment, veterinary clinics and pet owners also faced rising costs for medications, diagnostics, and preventive care, such as flea and tick treatments and vaccines. The economic uncertainty created by the tariffs further discouraged long-term purchasing commitments and complicated inventory planning for veterinary distributors and clinics. Many businesses resorted to stockpiling before tariff deadlines or searching for alternative suppliers, which introduced risks related to quality assurance and regulatory compliance.

Beyond cost implications, the tariffs also raised broader strategic concerns about the U.S. animal health sector’s dependency on Chinese supply chains. This prompted companies to reconsider their sourcing strategies, including exploring options from India, Europe, and Latin America, or investing in domestic manufacturing capabilities for veterinary drugs and APIs. However, shifting supply sources posed its own challenges, including higher base production costs, the need for re-approval of drugs with new ingredient sources, and delays due to regulatory review. For newer or smaller animal health firms, the burden of adapting to these structural changes was particularly heavy, affecting innovation pipelines and delaying the rollout of new products.

In the longer term, the Trump-era tariffs served as a wake-up call for stakeholders in the animal health industry to enhance supply chain resilience and reduce over-reliance on any single country for critical inputs. While the short-term effects included price volatility, supply disruptions, and operational stress, the longer-term outcome has been a gradual shift toward sourcing diversification, investment in local production facilities, and a more robust evaluation of geopolitical risks in procurement decisions. The industry began to explore collaborative efforts between governments, veterinary associations, and pharmaceutical companies to bolster domestic capacities and safeguard against future disruptions. Overall, the tariffs introduced an era of increased scrutiny and strategic planning within the animal health market, reinforcing the importance of adaptability and risk mitigation in an increasingly uncertain global trade environment.

Recent developments in Animal Health Market

In January 2025, WOAH launched The Animal Echo, a global online platform for sharing insights on animal health and welfare. This initiative provides stakeholders with resources to address challenges in animal health, food security, trade, and public health.

(Source:http://www.woah.org/en/woah-launches-the-animal-echo-a-global-knowledge-space-for-animal-health-and-welfare/

In December 2024, Zoetis launched Vetscan OptiCell, an AI-powered, cartridge-based hematology analyzer, at VMX 2025 in Orlando. Designed for canine and feline diagnostics, it delivers rapid, lab-quality results at the point of care, enhancing veterinary diagnostic efficiency

(Source:https://www.zoetisus.com/news-and-media/vetscan-opticell-vmx-press-release-posting/)

Conclusion

The animal health market is experiencing significant growth, driven by advancements in veterinary care, increasing pet ownership, and heightened awareness of animal well-being. The global animal health market was valued at USD 66.86 billion in 2025 and is projected to reach USD 156.43 billion by 2030, with a compound annual growth rate (CAGR) of 11.21%. This rapid expansion is indicative of the growing demand for animal health products and services, which are vital for ensuring the health and productivity of both companion and livestock animals. By 2031, the market is expected to maintain its momentum, contributing to a robust, sustainable future. Key segments within the animal health market include pharmaceuticals, vaccines, and feed additives, each playing an important role in the market's growth. The pharmaceuticals segment, encompassing treatments for diseases in companion animals and livestock, is projected to grow at a CAGR of 10.8%. Vaccines, which protect animals from a wide range of infectious diseases, will see a growth rate of 11.5%, while the feed additives segment, essential for improving livestock health and nutrition, is forecasted to expand at 11.3%.

North America, with its well-established veterinary care infrastructure and high levels of pet ownership, leads the global animal health market. The region is expected to continue its growth, expanding at a CAGR of 10.9%. Meanwhile, the Asia-Pacific region is rapidly emerging as a key growth driver due to increased livestock farming and rising pet adoption rates in countries like China, India, and Japan. This region is projected to grow at a CAGR of 11.8%, contributing significantly to the overall market expansion. Europe is also a major player in the animal health market, growing steadily at 11.2%, driven by increased focus on sustainable farming practices and the adoption of advanced veterinary solutions.

Innovation in the form of biologics, advanced diagnostic tools, and pet wellness products is reshaping the market. Biologic therapies, including monoclonal antibodies and gene therapies for animals, are making strides in treating complex diseases and improving the quality of life for companion animals. Furthermore, advancements in diagnostic technology, such as real-time health monitoring and diagnostic imaging, are enabling faster and more accurate disease detection. Additionally, there is a growing trend towards the development of nutraceuticals and functional foods for pets, reflecting a broader focus on preventative healthcare and holistic wellness. As consumer awareness around animal health increases and the demand for high-quality veterinary products and services grows, the market is expected to see substantial investment in research and development. Regulatory support for improving animal welfare, along with the increasing integration of digital health solutions for animals, will continue to fuel this market's expansion. With the focus on innovation, sustainability, and animal well-being, the animal health market is poised for substantial growth, offering significant opportunities for both established and emerging players.